Organization Overview
Alternative names
cyclophosphamide (cytoxan) (1 trial)
daclatasvir (daklinza) (1 trial)
Aggression (Phase 4)
Aggressive Periodontitis (Phase 4)
Alveolitis, Extrinsic Allergic (Phase 4)
Azoospermia (Phase 2)
Bacterial Infections (Phase 1)
Bladder Exstrophy (Phase 2)
Blood Loss, Surgical (Phase 2)
Brain Diseases (Phase 2)
Breast Neoplasms (Phase 1)
Chronic Periodontitis (Phase 1)
Colonic Neoplasms (Phase 1)
Communicable Diseases (Phase 4)
Dental Pulp Necrosis (Phase 3)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Nephropathies (Phase 3)
Diastasis, Bone (Phase 2)
Enuresis (Phase 2)
Helicobacter Infections (Phase 3)
Hemorrhage (Phase 4)
Hepatic Encephalopathy (Phase 2)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Hypersensitivity (Phase 4)
Infections (Phase 4)
Infertility (Phase 4)
Infertility, Female (Phase 4)
Infertility, Male (Phase 2)
Ischemia (Phase 4)
Kidney Diseases (Phase 3)
Klebsiella Infections (Phase 4)
Lupus Nephritis (Phase 4)
Macular Degeneration (Phase 2)
Menopause, Premature (Phase 2)
Necrosis (Phase 3)
Nephritis (Phase 4)
Ovarian Hyperstimulation Syndrome (Phase 4)
Periodontitis (Phase 4)
Pneumonia (Phase 4)
Postoperative Hemorrhage (Phase 2)
Postpartum Hemorrhage (Phase 4)
Premature Birth (Phase 2)
Primary Ovarian Insufficiency (Phase 2)
Skin Diseases (Phase 1)
Skin Neoplasms (Phase 1)
Syndrome (Phase 4)
Tinea (Phase 1)
Tinea Pedis (Phase 1)
Urinary Incontinence (Phase 2)